TCL Archive Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility February 1, 1980
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div. February 28, 1992
